SYMBAD
Synapses: from molecules to higher brain function and diseases
| Coordinatore | UNIVERSITE DE BORDEAUX
Organization address
address: PLACE PEY BERLAND 35 contact info |
| Nazionalità Coordinatore | France [FR] |
| Totale costo | 5˙057˙750 € |
| EC contributo | 5˙057˙750 € |
| Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | FP7-PEOPLE-ITN-2008 |
| Funding Scheme | MC-ITN |
| Anno di inizio | 2009 |
| Periodo (anno-mese-giorno) | 2009-12-01 - 2014-02-28 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
UNIVERSITE DE BORDEAUX
Organization address
address: PLACE PEY BERLAND 35 contact info |
FR (BORDEAUX) | coordinator | 0.00 |
| 2 |
UNIVERSITE VICTOR SEGALEN BORDEAUX II
Organization address
address: RUE LEO SAIGNAT 146 contact info |
FR (BORDEAUX CEDEX) | participant | 1˙698˙583.00 |
| 3 |
UNIVERSITE DE GENEVE
Organization address
address: Rue du General Dufour 24 contact info |
CH (GENEVE) | participant | 767˙364.00 |
| 4 |
UNIVERSITY OF BRISTOL
Organization address
address: TYNDALL AVENUE SENATE HOUSE contact info |
UK (BRISTOL) | participant | 706˙012.00 |
| 5 |
UNIVERSITA DEGLI STUDI DI MILANO
Organization address
address: Via Festa Del Perdono 7 contact info |
IT (MILANO) | participant | 522˙317.00 |
| 6 |
UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE
Organization address
address: AVENIDA DE LA UNIVERSIDAD S/N contact info |
ES (ELCHE) | participant | 460˙673.00 |
| 7 |
UNIVERSITAETSMEDIZIN GOETTINGEN - GEORG-AUGUST-UNIVERSITAET GOETTINGEN - STIFTUNG OEFFENTLICHEN RECHTS
Organization address
address: Robert-Koch-Strasse 40 contact info |
DE (GOETTINGEN) | participant | 393˙728.00 |
| 8 |
NEUROSEARCH AS
Organization address
address: Pederstrupvej 93 contact info |
DK (BALLERUP) | participant | 117˙405.00 |
| 9 |
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.
Organization address
address: Great West Road contact info |
UK (BRENTFORD) | participant | 101˙688.00 |
| 10 |
BIO-XTAL SARL
Organization address
address: ROUTE DE LA CHAPELLE 227 contact info |
FR (ST FELIX) | participant | 98˙493.00 |
| 11 |
NOSCIRA SA
Organization address
address: Calle Jose Abascal 2 contact info |
ES (MADRID) | participant | 92˙794.00 |
| 12 |
EXPLORA NOVA SARL
Organization address
address: RUE ALFRED KASTLER 15 contact info |
FR (LA ROCHELLE) | participant | 65˙762.00 |
| 13 |
AMPLITUDE SYSTEMES SA
Organization address
address: ALLEE DU DOYEN GEORGES BRUS 6 contact info |
FR (PESSAC) | participant | 32˙931.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'SyMBaD aims to move forward our knowledge on synapse structure and function in the normal and pathological brain. Brain diseases represent a considerable social and economic burden in Europe. Emerging evidence indicates that synaptic dysfunction is associated with a majority of neurological and psychiatric disorders. Novel therapeutical approaches relie on a better knowledge of the synapse and its pathologies. The network comprises 23 teams from 6 academic centres (Bordeaux, Alicante, Milan, Geneva, Göttingen, Bristol) representing an important fraction of the leading European researchers in the field. Synergies and complementarities between the research teams exist and should develop with the activities of the SyMBaD network. The participants are already well integrated in European scientific collaborative networks, and have an outstanding track-record of training young researchers. Industrial partners (6) will take part as full partners in training by an obligatory placement from 6 to 12 months of 16 ESR among the 26 recruited. The other ESR will be fully integrated into collaborative projects between academic teams. The private sector comprises companies involved in the development of new therapeutical strategies to combat brain diseases (GSK, Neurosearch, Xygen, and Noscira) and companies involved in technical development to be used in synaptic research and beyond (Bioxtal, Amplitude Systems, Explora Nova). The SYMBAD network aims to: • Teach a number of increasingly sophisticated techniques required in neuroscience and to advance towards novel therapies. • Focus on technological innovation and on interweaving of multilevel approaches. • Facilitate future constructive dialogue between academia and industry in the field by involving SMEs in the training of PhD students through collaborative research projects. SyMBaD will make European Neuroscience more attractive to young scientists, it will catalyze multi-level collaborations and foster intersectorial exchanges to advance in the study of some of the foremost Health issues of the European Community.'